260 related articles for article (PubMed ID: 32885175)
21. Influence of wild-type MLL on glucocorticoid sensitivity and response to DNA-damage in pediatric acute lymphoblastic leukemia.
Beesley AH; Rampellini JL; Palmer ML; Heng JY; Samuels AL; Firth MJ; Ford J; Kees UR
Mol Cancer; 2010 Oct; 9():284. PubMed ID: 20979663
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells.
Hulleman E; Kazemier KM; Holleman A; VanderWeele DJ; Rudin CM; Broekhuis MJ; Evans WE; Pieters R; Den Boer ML
Blood; 2009 Feb; 113(9):2014-21. PubMed ID: 18978206
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition.
Bachmann PS; Piazza RG; Janes ME; Wong NC; Davies C; Mogavero A; Bhadri VA; Szymanska B; Geninson G; Magistroni V; Cazzaniga G; Biondi A; Miranda-Saavedra D; Göttgens B; Saffery R; Craig JM; Marshall GM; Gambacorti-Passerini C; Pimanda JE; Lock RB
Blood; 2010 Oct; 116(16):3013-22. PubMed ID: 20647567
[TBL] [Abstract][Full Text] [Related]
24. Glucocorticoid-induced apoptosis and glucocorticoid resistance in acute lymphoblastic leukemia.
Ploner C; Schmidt S; Presul E; Renner K; Schröcksnadel K; Rainer J; Riml S; Kofler R
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):153-60. PubMed ID: 15860257
[TBL] [Abstract][Full Text] [Related]
25. NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells.
Paugh SW; Bonten EJ; Savic D; Ramsey LB; Thierfelder WE; Gurung P; Malireddi RK; Actis M; Mayasundari A; Min J; Coss DR; Laudermilk LT; Panetta JC; McCorkle JR; Fan Y; Crews KR; Stocco G; Wilkinson MR; Ferreira AM; Cheng C; Yang W; Karol SE; Fernandez CA; Diouf B; Smith C; Hicks JK; Zanut A; Giordanengo A; Crona D; Bianchi JJ; Holmfeldt L; Mullighan CG; den Boer ML; Pieters R; Jeha S; Dunwell TL; Latif F; Bhojwani D; Carroll WL; Pui CH; Myers RM; Guy RK; Kanneganti TD; Relling MV; Evans WE
Nat Genet; 2015 Jun; 47(6):607-14. PubMed ID: 25938942
[TBL] [Abstract][Full Text] [Related]
26. miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway.
Lucafò M; Sicari D; Chicco A; Curci D; Bellazzo A; Di Silvestre A; Pegolo C; Autry R; Cecchin E; De Iudicibus S; Collavin L; Evans W; Decorti G; Stocco G
Cancer Chemother Pharmacol; 2020 Sep; 86(3):361-374. PubMed ID: 32776229
[TBL] [Abstract][Full Text] [Related]
27. Src kinase-induced phosphorylation of annexin A2 mediates glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.
Spijkers-Hagelstein JA; Mimoso Pinhanços S; Schneider P; Pieters R; Stam RW
Leukemia; 2013 Apr; 27(5):1063-71. PubMed ID: 23334362
[TBL] [Abstract][Full Text] [Related]
28. Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance.
Wei G; Twomey D; Lamb J; Schlis K; Agarwal J; Stam RW; Opferman JT; Sallan SE; den Boer ML; Pieters R; Golub TR; Armstrong SA
Cancer Cell; 2006 Oct; 10(4):331-42. PubMed ID: 17010674
[TBL] [Abstract][Full Text] [Related]
29. PON2 blockade overcomes dexamethasone resistance in acute lymphoblastic leukemia.
Hui PY; Chen YH; Qin J; Jiang XH
Hematology; 2022 Dec; 27(1):32-42. PubMed ID: 34957927
[TBL] [Abstract][Full Text] [Related]
30. Glucocorticoid resistance in paediatric acute lymphoblastic leukaemia.
Bhadri VA; Trahair TN; Lock RB
J Paediatr Child Health; 2012 Aug; 48(8):634-40. PubMed ID: 22050419
[TBL] [Abstract][Full Text] [Related]
31. Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia.
Serafin V; Capuzzo G; Milani G; Minuzzo SA; Pinazza M; Bortolozzi R; Bresolin S; Porcù E; Frasson C; Indraccolo S; Basso G; Accordi B
Blood; 2017 Dec; 130(25):2750-2761. PubMed ID: 29101238
[TBL] [Abstract][Full Text] [Related]
32. Circumvention of glucocorticoid resistance in childhood leukemia.
Haarman EG; Kaspers GJ; Pieters R; Rottier MM; Veerman AJ
Leuk Res; 2008 Sep; 32(9):1417-23. PubMed ID: 18395253
[TBL] [Abstract][Full Text] [Related]
33. Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model.
Jones CL; Bhatla T; Blum R; Wang J; Paugh SW; Wen X; Bourgeois W; Bitterman DS; Raetz EA; Morrison DJ; Teachey DT; Evans WE; Garabedian MJ; Carroll WL
J Biol Chem; 2014 Jul; 289(30):20502-15. PubMed ID: 24895125
[TBL] [Abstract][Full Text] [Related]
34. Differential network analysis and protein-protein interaction study reveals active protein modules in glucocorticoid resistance for infant acute lymphoblastic leukemia.
Mousavian Z; Nowzari-Dalini A; Rahmatallah Y; Masoudi-Nejad A
Mol Med; 2019 Aug; 25(1):36. PubMed ID: 31370801
[TBL] [Abstract][Full Text] [Related]
35. Glucocorticoid-induced granzyme A expression can be used as a marker of glucocorticoid sensitivity for acute lymphoblastic leukemia therapy.
Myoumoto A; Nakatani K; Koshimizu TA; Matsubara H; Adachi S; Tsujimoto G
J Hum Genet; 2007; 52(4):328-333. PubMed ID: 17310274
[TBL] [Abstract][Full Text] [Related]
36. Chemical genomic screening identifies LY294002 as a modulator of glucocorticoid resistance in MLL-rearranged infant ALL.
Spijkers-Hagelstein JA; Pinhanços SS; Schneider P; Pieters R; Stam RW
Leukemia; 2014 Apr; 28(4):761-9. PubMed ID: 23958920
[TBL] [Abstract][Full Text] [Related]
37. Receptor mutation is not a common mechanism of naturally occurring glucocorticoid resistance in leukaemia cell lines.
Beesley AH; Weller RE; Senanayake S; Welch M; Kees UR
Leuk Res; 2009 Feb; 33(2):321-5. PubMed ID: 18789525
[TBL] [Abstract][Full Text] [Related]
38. A novel method to establish glucocorticoid resistant acute lymphoblastic leukemia cell lines.
Gu L; Zhang G; Zhang Y
J Exp Clin Cancer Res; 2019 Jun; 38(1):269. PubMed ID: 31221196
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxicity of cortivazol in childhood acute lymphoblastic leukemia.
Styczynski J; Kurylak A; Wysocki M
Anticancer Res; 2005; 25(3B):2253-8. PubMed ID: 16158972
[TBL] [Abstract][Full Text] [Related]
40. MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia.
Jones CL; Gearheart CM; Fosmire S; Delgado-Martin C; Evensen NA; Bride K; Waanders AJ; Pais F; Wang J; Bhatla T; Bitterman DS; de Rijk SR; Bourgeois W; Dandekar S; Park E; Burleson TM; Madhusoodhan PP; Teachey DT; Raetz EA; Hermiston ML; Müschen M; Loh ML; Hunger SP; Zhang J; Garabedian MJ; Porter CC; Carroll WL
Blood; 2015 Nov; 126(19):2202-12. PubMed ID: 26324703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]